EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

mRNA Delivery: Challenges and Advances through Polymeric Soft Nanoparticles

Samaneh Yousefi Adlsadabad, John W Hanrahan iD, Ashok Kakkar

International Journal of Molecular Sciences · 01.02.2024 · 25 (3) · 1739

DOI: 10.3390/ijms25031739 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 01.02.2024. Verfasst von Samaneh Yousefi Adlsadabad und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, McGill University, 801 Sherbrooke St West, Montreal, QC H3A 0B8, Canada. Hauptthemen laut MEDLINE: COVID-19 Vaccines, Nanoparticles. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 136 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: New Frontiers in Research Fund - Exploration (NFRFE, Canada), the Natural Sciences and Engineering Research Council (NSERC, Canada), Natural Sciences and Engineering Research Council (NSERC, Canada).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Single-stranded messenger ribonucleic acid (mRNA) plays a pivotal role in transferring genetic information, and tremendous effort has been devoted over the years to utilize its transcription efficacy in therapeutic interventions for a variety of diseases with high morbidity and mortality. Lipid nanocarriers have been extensively investigated for mRNA delivery and enabled the rapid and successful development of mRNA vaccines against SARS-CoV-2. Some constraints of lipid nanocarriers have encouraged the development of alternative delivery systems, such as polymer-based soft nanoparticles, which offer a modular gene delivery platform. Such macromolecule-based nanocarriers can be synthetically articulated for tailored parameters including mRNA protection, loading efficacy, and targeted release. In this review, we highlight recent advances in the development of polymeric architectures for mRNA delivery, their limitations, and the challenges that still exist, with the aim of expediting further research and the clinical translation of such formulations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19 VaccinesNanoparticlesHumansLipidsPolymersRNA, Messenger

Stichwörter der Autor:innen

cationic and non-cationic polymersmRNA therapeuticspolymer lipid hybrid systems

Substanzen

COVID-19 VaccinesLipidsPolymersRNA, Messenger

Autor:innen und Institutionen

  • Department of Chemistry, McGill University, 801 Sherbrooke St West, Montreal, QC H3A 0B8, Canada.
  • Department of Physiology, McGill University, 3655 Promenade Sir-William-Osler, Montreal, QC H3G 1Y6, Canada.

ORCID-Profile: John W Hanrahan

Förderung

  • New Frontiers in Research Fund - Exploration (NFRFE, Canada)
  • the Natural Sciences and Engineering Research Council (NSERC, Canada)
  • Natural Sciences and Engineering Research Council (NSERC, Canada)
  • New Frontiers in Research Fund-Exploration (NFRFE, Canada)

Zitieren

APA

Yousefi Adlsadabad, S., Hanrahan, J. W., & Kakkar, A. (2024). mRNA Delivery: Challenges and Advances through Polymeric Soft Nanoparticles. International Journal of Molecular Sciences, 25(3), 1739. https://doi.org/10.3390/ijms25031739

Vancouver

Yousefi Adlsadabad S, Hanrahan JW, Kakkar A. mRNA Delivery: Challenges and Advances through Polymeric Soft Nanoparticles. International Journal of Molecular Sciences. 2024;25(3):1739. doi:10.3390/ijms25031739

BibTeX
@article{YousefiAdlsadabad2024,
  author = {Yousefi Adlsadabad, Samaneh and Hanrahan, John W and Kakkar, Ashok},
  title = {mRNA Delivery: Challenges and Advances through Polymeric Soft Nanoparticles},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {3},
  pages = {1739},
  doi = {10.3390/ijms25031739}
}
Kostenlos starten →